Search Index

CRISPR-Cas9, CAR T-cells, incretins, and iPSCs Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Biggest Innovations in Biosciences 09/03/26, 15:00 Last updated: Published: 25/03/24, 11:43 CRISPR-Cas9, CAR T-cells, incretins, and iPSCs We are in the era of innovation and cutting-edge technology in biosciences and health. This article goes through some of the most remarkable technologies slowly conquering the world of biosciences. Gene editing and CRISPR-Cas9 Gene editing is based on the idea that correcting the genetic mistake that causes a disease offers a permanent result than curing the symptoms. This technique allows scientists to alter the DNA of cells by deleting, adding or modifying genes. There are numerous ways to edit a gene. The most widely used and revolutionary method for gene editing is CRISPR-Cas9, which stands for Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR- associated protein 9. The process begins with the design of a synthetic RNA molecule, known as guide RNA (gRNA) that matches the target gene sequence. The gRNA, combined with the Cas9 protein, forms a complex that is then introduced into the target cells. Cas9 acts like scissors, guided by the gRNA, to locate the precise location on the DNA where the genetic modification is intended. Once the target site is identified, Cas9 induces a break in the DNA strand. The cell's natural DNA repair mechanisms then come into play. The non- homologous end joining pathway introduces insertions and deletions at the site, resulting in gene knockout or inactivation. On the other hand, once a DNA template with homology to the sequences is present, the homology-directed repair pathway allows the incorporation of a desired genetic sequence, facilitating gene insertion or replacement. Several other gene-editing techniques have been developed, each with unique approaches. Zinc Finger Nucleases (ZFNs) and Transcription Activator-Like Effector Nucleases (TALENs) are two examples. These methods also use proteins that act as molecular scissors to cut the DNA at specific locations. ZFNs use zinc finger proteins to bind to target DNA sequences, while TALENs use transcription activator-like effector proteins. As the field of gene editing rapidly advances, these diverse methods contribute to the expanding toolkit available for researchers and hold promise for addressing a wide array of applications, from medical treatments to agricultural improvements. CAR T-cells Chimeric antigen receptor T-cells (CAR T-cells) are a new type of immunotherapy, considered to be the new fighters in the war on cancer. In general, immunotherapies use the patient’s immune system to fight the cancer. This therapy promises more specificity than traditional therapies and more permanent results. T-cells naturally exist in the human organism, supporting the adaptive immune system. They are a group of lymphocytes in the blood or lymph tissue that target or kill specific pathogens. Each type of T-cell recognises specific pathogens. T-cells have proteins on their outer surface, called receptors and these receptors recognize specific proteins on the outer surface of the pathogen. Depending on the type of T-cell, after recognizing the specific pathogen, they are either killing the pathogen (killer T-cells) or signaling to other elements of immune system to attack the pathogen (helper T-cells). CAR T-cell therapy involves modifying a patient’s own T-cells to express a specific CAR on their surface. The receptor is designed to recognise antigens commonly found on the surface of cancer cells. To introduce CARs on the outer surface of T-cells, the patient’s T-cells are genetically modified in the lab. A viral vector is often used to knock out the original T-cell receptors and express the CAR construct. The newly created CAR-T-cells are introduced into the patients, where they target and destroy cancer cells expressing the specific antigen for which the CAR is designed. Incretins The scientific journal “Science” proclaimed glucagon-like peptide-1 (GLP-1) receptor agonists The Breakthrough of 2023. These medications, originally approved for type 2 diabetes, demonstrated remarkable weight-loss benefits. GLP-1 is a natural hormone produced in the intestines that plays a role in regulating blood sugar levels. When we eat a meal, incretins, GLP-1 and Glucose-dependent insulinotropic polypeptide (GIP), are released into the bloodstream. They bind to specific receptors on the beta cells of the pancreas, triggering insulin release. Incretins also suppress the release of glucagon, a hormone that increases blood sugar levels by promoting the breakdown of stored glucose. GLP-1 receptor agonists are medications that mimic the effects of GLP-1. They bind to the GLP-1 receptors on pancreatic beta cells, promoting insulin secretion and suppressing glucagon release. By mimicking the actions of GLP-1, these medications help to lower sugar levels, improve glucose control, and reduce the risk of hypoglycemia. At the same time, they seem to regulate the appetite and delay gastric emptying. New GLP-1 medicines have been produced to combat weight loss with high efficacies; some are available on the NHS while others can be purchased privately. iPSCs Induced pluripotent stem cells (iPSCs) are becoming a new powerful weapon in lab research. They are a type of stem cell that can be generated from adult cells, such as skin or blood cells, through reprogramming. The process of creating iPSCs involves introducing a set of specific genes into the adult cells. These reprogramming factors reset the adult cells' developmental clock, turning them back into a pluripotent state, similar to embryonic stem cells. Once iPSCs are generated, they can be expanded indefinitely in the laboratory and induced to differentiate into various cell types. iPSCs are a valuable tool for studying human development and disease, as well as for drug discovery and regenerative medicine. iPSCs can be derived from patients with genetic diseases or other conditions, allowing researchers to study disease mechanisms in a dish. By differentiating iPSCs into the relevant cell types affected by the disease, researchers can observe how the disease develops and test potential treatments. Moreover, iPSC-derived cells can screen potential drugs for safety and efficacy. Because iPSCs can differentiate into many different cell types, they provide a more accurate model of human biology than traditional cell culture methods. Finally, because iPSCs can be derived from individual patients, they offer the potential for personalised therapies. iPSCs could be used to generate patient-specific cells for transplantation or to test drugs for individual patients. Conclusion These cutting-edge technologies offer unprecedented opportunities for targeted interventions in the treatment of genetic disorders, cancer, diabetes, and a myriad of other diseases. However alongside their immense promise, these biotechnological techniques and therapies also raise important ethical, social and regulatory considerations. The implications of gene editing on human germline cells, the accessibility of advanced therapies, and the long-term safety of these interventions are critical areas that warrant careful attention and thoughtful deliberation. Embracing these innovative techniques with diligence holds the key to unlocking a future where previously incurable conditions become manageable, and where the boundaries of medical possibility are continually expanded. Written by Matina Laskou Related articles: Medical biotechnology / Mesenchymal stem cells Project Gallery

Treatment that effectively controls tumours and prolongs survival without side effects Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A breakthrough in prostate cancer treatment 08/07/25, 14:35 Last updated: Published: 04/04/24, 16:00 Treatment that effectively controls tumours and prolongs survival without side effects Introduction Prostate cancer is a devastating disease that affects millions of men worldwide. Despite advancements in treatment options, aggressive forms of the disease, such as metastatic castrate-resistant prostate cancer (mCRPC), remain a major challenge. However, a recent study conducted by researchers at the University of Chicago Medicine Comprehensive Cancer Centre has established a promising "proof-of-concept" for a new treatment approach that could revolutionize the field. The study, published in Clinical Cancer Research, demonstrated the remarkable effectiveness of this novel treatment in a mouse model of advanced prostate cancer. The researchers achieved complete tumour control and long-lasting survival without any side effects. These ground-breaking findings have paved the way for further investigation in human clinical trials. Finding the exact cancer cell and then destroying it but leaving the healthy tissue untouched. In theory, it could be like aiming and shooting at someone in the video game but real world is a bit different, isn’t it? Overcoming Resistance to Hormonal Therapy Hormonal therapy, specifically androgen deprivation therapy (ADT), is the standard treatment for metastatic prostate cancer. However, the majority of patients eventually develop resistance to this therapy, leading to castrate-resistant prostate cancer. This resistance poses a significant challenge for clinicians and leaves patients with limited treatment options. Dr. Akash Patnaik, an accomplished physician-scientist and renowned expert in prostate cancer research and treatment, and his team at the University of Chicago Medical Centre have been exploring new strategies to overcome this resistance. Their research focuses on harnessing the immune system's ability to combat cancer cells. Targeting Macrophages to Control Cancer Growth Dr. Patnaik's team discovered that macrophages, a type of immune cell, play a crucial role in promoting the growth of prostate cancer. These macrophages express a molecule called PD-1, which suppresses the anti-cancer immune response. By targeting these macrophages, the researchers aimed to control the growth of the cancer. In a previous study, the team found that co-targeting the PI3K and PD-1 pathways enhanced the effects of hormonal therapy in PTEN-deficient prostate cancer, a particularly aggressive form of the disease. However, a significant portion of the mice remained resistant to this therapy. Further investigations revealed that the activation of the Wnt/β-catenin pathway restored lactate production in these treatment-resistant cancers, leading to macrophages promoting tumour growth. A Novel Therapeutic Approach Building on their previous findings, Dr. Patnaik and his team developed a novel therapeutic approach. By co-targeting the PI3K, MEK, and Wnt/β-catenin signalling pathways, they achieved an impressive 80% response rate in mouse models. However, a small percentage of the mice still showed resistance due to the restoration of lactate production in the treatment-resistant cancers. This led the researchers to investigate further and uncover the mechanism behind this resistance. They discovered that lactate can interact with macrophages and modify them through a process called histone lactylation, making the macrophages immunosuppressive and promoting cancer growth. In their latest study, the researchers found that targeting lactate as a macrophage phagocytic checkpoint can effectively control the growth of PTEN/p53-deficient prostate cancer. Through intermittent dosing of the three drugs, they achieved complete tumor control and significantly prolonged survival without the long-term toxicity associated with continuous drug administration. These groundbreaking findings provide "proof-of-concept" for a new treatment approach that holds great promise for the most aggressive forms of prostate cancer. The researchers believe that their strategy of harnessing the ability of macrophages to eliminate cancer cells could revolutionize cancer therapy. By flipping the switch in macrophages, the cancer cells can be effectively controlled and eliminated. The next step for Dr. Patnaik and his team is to translate these findings into clinical trials. They plan to develop a phase 1 clinical trial to test the efficacy of the intermittent dosing approach in human patients. If successful, this approach could potentially offer a new therapeutic option for patients with metastatic castrate-resistant prostate cancer, who currently have limited treatment options. The potential of this novel therapeutic approach extends beyond prostate cancer. The researchers have also uncovered new therapeutic opportunities by perturbing signaling pathways in cancer cells that affect the metabolic output of the cancer cell and its interaction with tumor-promoting macrophages. This opens up new avenues for research and the development of targeted therapies for various types of cancer. Conclusion The research conducted by Dr. Patnaik and his team has demonstrated the effectiveness of co-targeting multiple signaling pathways in treating aggressive forms of prostate cancer. Their findings provide a solid foundation for further investigation in human clinical trials and offer hope for patients with limited treatment options. This novel therapeutic approach has the potential to revolutionize cancer therapy and pave the way for more targeted and effective treatments in the future. Written by Sara Maria Majernikova Related article: A breakthrough drug discovery in cancer treatment References: Chaudagar, K., et al . (2023) Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. Clinical Cancer Research . doi.org/10.1158/1078-0432.CCR-23-1441 Chetta, P., Sriram, R. and Zadra, G. (2023) ‘Lactate as key metabolite in prostate cancer progression: What are the clinical implications?’, Cancers , 15(13), p. 3473. doi: https://doi.org/10.3390/cancers15133473 . Mathieu (2023) Revolutionary breakthrough in prostate cancer treatment at the University of Bern , Greater Geneva Bern area . Available at: https://ggba.swiss/en/revolutionary-breakthrough-in-prostate-cancer-treatment-at-the-university-of-bern/(Accessed: 29 September 2023). Project Gallery

The importance of implementing Maths into our lives Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Teaching maths like it matters 11/07/25, 09:54 Last updated: Published: 03/10/23, 13:43 The importance of implementing Maths into our lives …But I’m never going to use Algebra in my life! The above is a typical response from students across the country when walking into a Maths class. I did not understand others’ disdain, because I love Maths. I got satisfaction from solving numerical problems, stimulation from equations, and excitement from learning new variables like alpha, or constants like Pi. The abstract nature of Maths was like art to me. Later, I realised that not all my peers felt the same way, that somehow, I was the anomaly and that they were the norm. Many maths teachers feel the same way. They get lost in the subject that they love and try to teach it in the way that makes sense to them, without thinking on how the lack of context in equations and processes means nothing to disengaged students. As teachers, our job is to show how applicable Maths can be to our students on an individual basis. Rather than using real-life questions as extensions after the core activity, we must utilise them from the beginning when introducing topics, showing student’s how the methods that they learn can be applied to have some use beyond a pass mark in their exams. I am not talking about examples of ladders leaning against walls when teaching Pythagoras’ theorem and SOHCAHTOA, or, taking counters from a bag, to explain Probability. The examples here are forced, no student will connect with them because they are not lived examples or likely scenarios in most of their lives. We need to build strong relationships with our students, understand their demographic and interests, then introduce topics based on this. For example: If I know that my class enjoys football, I will begin with a video of Messi playing the game, pausing the video, and splitting the pitch up into segments, which can lead a conversation into areas of segments and circles, or, I can discuss the trajectory of the ball after a kick, to talk about quadratic equations. In another class, we can ask what students are budgeting for, perhaps concert tickets or new clothes, and use that to open a discussion into arithmetic series. Another great example is asking students to find an event happening somewhere in the country that they would like to go to, and as a class, plan for this. We would use research skills, calculate speed, distance and time if going by car, or pull up a train timetable where we can teach two-way tables and time conversions. To create meaningful connections to Math topics will take time, effort, and research, and the difficulty will be that not every application will be relatable to every cohort. We will need to build a portfolio of contextual examples related to each topic, however, if there is buy-in from others in our departments, it is an achievable target. In conclusion, we must teach Maths to students in meaningful ways that applies to their life, to keep up engagement and motivation as well as providing opportunities to deepen understanding. Maths should be based around conversation and interests, rather than an exercise of memorising and processes. It should make sense to students, it should matter. Written by Sara Altaf Related article: The game of life Project Gallery

iPSCs are one of the most powerful tools of biosciences Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The endless possibilities of iPSCs and organoids 11/07/25, 10:02 Last updated: Published: 20/01/24, 11:50 iPSCs are one of the most powerful tools of biosciences On the 8th of October 2012, the Nobel Prize in Physiology was given to Shinya Yamanaka and John B. Gurdon for a groundbreaking discovery; induced Pluripotent Stem Cells (iPSCs). The two scientists discovered that mature, specialised cells can be reprogrammed to their initial state and consequently transformed into any cell type. These cells can be used to study disease, examine genetic variations and test new treatments. The science behind iPSCs The creation of iPSCs is based on the procedure of cell potency during mammalian development. While the organism is still in the embryonic stage, the first cell developed is a totipotent stem cell, which has the unique ability to differentiate into any cell type in the human body. “Totipotent” refers to the cell’s potential to give rise to all cell types and tissues needed to develop an entire organism. As the totipotent cell grows, it develops into the pluripotent cell, which can differentiate into the three types of germ layers; the endoderm line, the mesoderm line and the ectoderm line. The cells of each line then develop into multipotent cells, which are derived into all types of human somatic cells, such as neuronal cells, blood cells, muscle cells, skin cells, etc. Creation of iPSCs and organoids iPSCs are produced through a process called cellular reprogramming, which involves the reprogramming of differentiated cells to revert to a pluripotent state, similar to that of embryonic stem cells. The process begins with selecting any type of somatic cell from the individual (in most cases, the individual is a patient). Four transcription factors, Oct4, Sox2, Klf4 and c-Myc, are introduced into the selected cells. These transcription factors are important for the maintenance of pluripotency. They are able to activate the silenced pluripotency genes of the adult somatic cells and turn off the genes associated with differentiation. The somatic cells are now transformed into iPSCs, which can differentiate into any somatic cell type if provided with the right transcription factor. Although iPSCs themselves have endless applications in biosciences, they can also be transformed into organoids, miniature three-dimensional organ models. To create organoids, iPSCs are exposed to a specific combination of signalling molecules and growth factors that mimic the development of the desired organ. Current applications of iPSCs As mentioned earlier, iPSCs can be used to study disease mechanisms, develop personalised therapies and test the action of drugs in human-derived tissues. iPSCs have already been used to model cardiomyocytes, neuronal cells, keratinocytes, melanocytes and many other types of cells. Moreover, kidney, liver, lung, stomach, intestine, and brain organoids have already been produced. In the meantime, diseases such as cardiomyopathy, Alzheimer’s disease, cystic fibrosis and blood disorders have been successfully modelled and studied with the use of iPSCs. Most importantly, the use of iPSCs in all parts of scientific research reduces or replaces the use of animal models, promising a more ethical future in biosciences. Conclusion iPSCs are one of the most powerful tools of biosciences at the moment. In combination with gene editing techniques, iPSCs give accessibility to a wide range of tissues and human disorders and open the doors for precise, personalised and innovative therapies. iPSCs not only promise accurate scientific research but also ethical studies that minimise the use of animal models and embryonic cells. Written by Matina Laskou Related articles: Organoids in drug discovery / Introduction to stem cells Project Gallery

And a hope for a more sustainable future Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Green Chemistry 04/04/26, 17:32 Last updated: Published: 29/06/23, 10:33 And a hope for a more sustainable future Green Chemistry is a branch of chemistry that takes into consideration the design of synthetic reactions to minimise the generation of hazardous by-products, their impact on humans and the environment. Often reactions are designed to take place at low temperatures with short reaction times and increased yields. This is preferred as fewer materials are used and it is more energy efficient. When designing routes it is important to consider ‘How green is the process?’ in this way we are shifting focus to a more sustainable future where we are emitting fewer pollutants, using renewable feedstocks and energy sources with minimal waste. In 1998, Paul Anastas and John Warner devised the twelve principles of Green Chemistry. They serve as a framework for scientists to design innovative scientific solutions to existing and new synthetic routes. Scientists are looking into environmentally friendly reaction schemes which can simplify production as well as being able to use greener resources. It is impossible to fulfil all twelve principles at the same time but making attempts to apply as many principles as possible when designing a protocol is just as good. The twelve principles are: Prevention: waste should be prevented rather than treating waste after it has been created. Atom Economy: designing processes where you are maximising the incorporation of all materials so all reagents are in the final product. Less Hazardous Chemical Synthesis : synthetic methods should be designed to be safe and the hazards of all the substances should be reviewed. Designing Safer Chemicals: designed to eliminate chemicals which are carcinogenic, neurotoxic, etc. essentially safe to the Earth. Safer Solvents and Auxiliaries: using auxiliary substances and minimising usage of solvents to reduce waste created. Design for Energy Efficiency: designing synthetic methods where reactions can be conducted at ambient temperature and pressure. Use of Renewable Feedstock: raw materials used for reactions should be renewable rather than depleting. Reduce Derivatives: reducing the steps required in a reaction by using catalysts/ enzymes and adding protecting or deprotecting groups or temporary modification of functionality. Extra steps require more reagents and generate a lot of waste. Catalysis: catalysts lower energy consumption and increase reaction rates. They allow for decreased use of harmful and toxic chemicals. Design for Degradation: chemical products should be designed so that they can break down and have no harmful effects on the environment. Real-time analysis for Pollution Prevention: analytical techniques required to allow monitoring of the formation of hazardous substances. Inherently Safer Chemistry for Accident Prevention: involves using safer chemical alternatives to prevent the occurrence of an accident e.g. fires; explosions. Some examples of areas where Green Chemistry is implemented: Computer Chips: the use of supercritical carbon dioxide as a step for the preparation of a chip. This has reduced the quantities of chemicals, water and energy required to produce chips. Medicine: developing more efficient ways of synthesising pharmaceuticals e.g. chemotherapy drug Taxol. Green Chemistry is widely being implemented in academic labs as a way to reduce the environmental impact and high costs. In 2026, green chemistry has evolved from a niche sustainability goal into a $1 trillion global industry. This branch in Chemistry is still fairly new and will likely be one of the most important fields in the future. Written by Khushleen Kaur Related article: The challenges in modern day chemistry Project Gallery

Based on the ideas of Aristippus and Aristotle Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A perspective on well-being: hedonic VS eudaimonic well-being 08/07/25, 16:16 Last updated: Published: 02/07/24, 10:51 Based on the ideas of Aristippus and Aristotle Since ancient times well-being has been discussed in two broad domains: hedonic and eudaimonic. Hedonic well-being is based on the ideas of Aristippus, who proposed that the ultimate aim of all human endeavours and pursuits is pleasure (hedonism). Therefore, hedonic well-being (aka subjective well-being) is a shorter-term evaluation of well-being that balances between positive and negative emotions and between pleasure attainment and pain avoidance. A real-life example of behaviour that leads to hedonic happiness is spending a large amount of money on a designer item to satisfy the need to stay current with fashion trends. According to Keyes et al. (2002), the three aspects of subjective well-being are positive affect (mood), negative affect (mood) and life satisfaction. The most common tools used to measure subjective well-being are the Positive and Negative Affect Schedule (PANAS) by Watson, Clark & Tellegen (1988) and the Satisfaction with Life Scale (SWLS) by Diener et al. (1985). Subjective well-being has been associated with having a present temporal focus and higher income levels, suggesting it is grounded in physical aspects of life and not the greater goals of self-actualisation. On the other hand, eudaimonic well-being is based on the philosophy of Aristotle, who argued that humans can only achieve true happiness and flourish by finding meaning and purpose in life (eudaimonia). Thus, eudaimonic well-being (aka psychological well-being) is a longer-term evaluation of well-being that results from engagement with development and challenges in life posed during the search for meaning and self-reflection. An example of an action that leads to eudaimonic happiness is reading philosophical books and learning more about life holistically. According to Keyes et al. (2002), the six aspects of psychological well-being are autonomy, environmental mastery, personal growth, purpose in life, positive relations with others and self-acceptance. The Scales of Psychological Well-being by Riff (1989) are often used to measure eudaimonic well-being. Recent research shows that psychological well-being is associated with higher levels of self-compassion, mindfulness practices and exposure to natural environments. Therefore, hedonic and eudaimonic well-being represent distinct perspectives on life. Hedonic well-being is more focused on a person's present emotional state and evaluation of their current life circumstances, whereas eudaimonic well-being takes a longer-term view, considering how well a person is functioning and developing their potential over time. The two different types of well-being also are related to separate life outcomes. Higher subjective well-being is associated with better physical health, longevity and relationship quality; while greater psychological well-being is linked to resilience, continued personal growth and self-actualisation. Whilst perhaps it is impossible to determine which well-being is more beneficial, it is definite that hedonic and eudaimonic well-being are intertwined into our daily lives. Written by Aleksandra Lib Related articles: Motivating the mind / Environmental factors and exercise / Physical and mental health / Life under occupation REFERENCES Diener, E., & Chan, M. Y. (2011). Happy people live longer: Subjective well-being contributes to health and longevity. Applied Psychology: Health and Well-Being, 3 (1), 1-43. Diener, E. D., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The satisfaction with life scale. Journal of personality assessment , 49 (1), 71-75. Howell, A. J., Passmore, H.-A., & Holder, M. D. (2023). Savoring the here and now: The role of temporal focus for well-being. Journal of Positive Psychology, 18 (2), 221-236. Keyes, C. L., Shmotkin, D., & Ryff, C. D. (2002). Optimizing well-being: the empirical encounter of two traditions. Journal of personality and social psychology , 82 (6), 1007. Koo, J., & Park, K. (2022). Does money buy happiness after all? Revisiting the income-wellbeing link. Journal of Happiness Studies, 23 (3), 1133-1154. Mair, C., Jarrett, M., Watson, M., & Jones, P. B. (2022). The impact of nature exposure on psychological well-being: A systematic review. Environmental Research, 208 , 112677. Krieger, T., Hermann, H., Zimmermann, J., & grosse Holtforth, M. (2022). The role of self-compassion in promoting psychological well-being during the COVID-19 pandemic. Journal of Counseling Psychology, 69 (4), 380–396. Ryff, C.D. (1989). Happiness is everything, or is it? Explorations on the meaning of psychological well-being. Journal of Personality and Social Psychology 57 , 1069–1081. Ryff, C. D. (2014). Psychological well-being revisited: Advances in the science and practice of eudaimonia. Psychotherapy and Psychosomatics, 83 (1), 10-28. Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. Journal of personality and social psychology , 54 (6), 1063. Project Gallery

Pushing the boundaries of analytical chemistry Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Advances in mass spectrometry technology 05/06/26, 20:29 Last updated: Published: 09/06/24, 10:48 Pushing the boundaries of analytical chemistry In the rapidly evolving field of analytical chemistry, recent technological innovations in mass spectrometry have revolutionised the analysis and characterisation of molecules. These advancements, including high-resolution mass analysers, ion mobility spectrometry (IMS), and ambient ionisation techniques, are pushing the boundaries of what can be achieved in chemical analysis. Mass spectrometry is a powerful analytical technique that provides qualitative and quantitative information on an analyte. It is useful for measuring the mass-to-charge ratio (m/z) of one or more molecules present in a sample. The process consists of: Inlet - Allows the analyte to be connected to the mass spectrometre (MS). Could be direct inlet or gas chromotography (GC) / liquid chromatography (LC) to allow some separation before MS Ion source - Ensures that the analyte is ionised (i.e. carries a net charge) there are various types of ion sources depending on the analyte Analysers - Brings about a change in the velocity/trajectory of an ion from which the ions m/z can be determined i.e. characterises rate/velocity of ion. Multiple analysers are in tandem and different analysers can be combined to allow greater scope for analysis. A detection system is also required to amplify and measure ion signals. Analysers and detectors need to be held under low pressure - near vacuum. Detector - collects charge signals from ion beams. The computer then detects a spectrum. The electronic signals from the ions are then digitised to produce a mass spectrum of the analyte. High-resolution mass analysers One of the most significant breakthroughs in mass spectrometry is the development of high-resolution mass analysers. These instruments can differentiate between ions with extremely close mass-to-charge ratios, providing unprecedented levels of accuracy and specificity in compound identification. High-resolution mass spectrometry enables scientists to resolve complex mixtures and detect trace components with exceptional sensitivity, making it invaluable in fields such as metabolomics, environmental analysis, and drug discovery. Ion Mobility Spectrometry (IMS) Ion mobility spectrometry is another cutting-edge technology that enhances the capabilities of mass spectrometry. IMS separates ions based on their size, shape, and charge in the gas phase, providing an additional dimension of separation before mass analysis. This technique improves the resolution of complex samples, particularly for isomeric compounds that are challenging to distinguish using conventional methods. IMS coupled with mass spectrometry is widely applied in metabolomics, proteomics, and lipidomics research, enabling deeper insights into molecular structures and interactions. Ambient ionisation techniques Traditional mass spectrometry methods often require extensive sample preparation and ionisation processes in controlled laboratory environments. Ambient ionisation techniques have transformed this paradigm by enabling direct analysis of samples in their native states, including solids, liquids, and gases, without prior extraction or purification steps. Techniques such as desorption electrospray ionisation (DESI) and direct analysis in real-time (DART) have expanded the scope of mass spectrometry applications to fields like clinical diagnostics, food safety, and forensic analysis. Ambient ionisation allows for rapid, on-site measurements with minimal sample handling, revolutionising point-of-care testing and field analysis. In conclusion, the continuous evolution of mass spectrometry technology is reshaping the landscape of analytical chemistry. These innovations not only empower researchers to explore new realms of chemical analysis but also facilitate applications in areas such as precision medicine, environmental monitoring, and materials science. As these technologies continue to advance, the future holds even greater promise for pushing the boundaries of analytical chemistry and unlocking the mysteries of the molecular world. Written by Anam Ahmed Related articles: Advancements in semi-conductor manufacturing / Inorganic NMR Project Gallery

It's in the diet Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link How epigenetic modification gives the queen bee her crown 23/01/25, 11:52 Last updated: Published: 26/11/23, 10:46 It's in the diet Honey bee colonies are comprised of three kinds of adult bees: workers, drones and a single queen. While all drones are male, the queen and the worker bees are female. Within the female population, only the queen bee is fertile and is thus responsible for laying eggs which are fertilised by drones. Additionally, a queen bee is larger than worker bees and produces pheromones to allow the colony to function. However, worker and queen bees are genetically identical, so how is it possible that they are so fundamentally different? ( Figure 1 ) The answer lies in epigenetic modification , defined as the alteration in gene function without a change in the DNA sequence. Types of epigenetic regulation include histone modification, DNA methylation and action of noncoding RNA. The honey bee Apis mellifera is amongst the many species that can produce different characteristics of organisms using the same genome. The mechanism by which honey bees do this derives from epigenetic modification resulting from the difference in diet during larval development. All larvae feed on royal jelly during the first three days of their development ( Figure 2 ). However, worker larvae will then feed on a diet of honey and pollen, which constitutes worker jelly. In comparison, the queen larva maintains a diet of royal jelly; this is a complex mixture produced by nurse bees and contains water, crude protein, monosaccharides, and fatty acids. Subsequently, the difference in dietary intake provides information to facilitate the correct epigenome which in turn allows correct transcription. Thus, key studies have taken place to investigate the effect of epigenetic marks on the development of bees. DNA methyltransferase DNMT3 is responsible for the methylation of DNA and is a repressive mark; a study found that the silencing of DNMT3 resulted in worker larvae developing into queens that had developed ovaries. Consequently, this shows that royal jelly gives information to larvae destined to be queens that can be interpreted to apply the correct epigenome. Additionally, certain histone deacetylase inhibitors have been observed in royal jelly including the compound 10 HDA and phenylbutyrate. Histone acetylation within regions of the genome results in chromatin opening; acetylation is associated with active regions. HDACi activity will inhibit the removal of such acetylation and maintain open regions of DNA. However, note that worker bees are not just a repressed version of queen bees, as they have overexpressed genes of their own to facilitate their specific behaviours. On examination of the methylome (see Figure 3 ), different genes were identified as being hypo- or hyper- methylated within worker vs queen bees. See the table below for a detailed analysis of worker and queen bees on days 3-5 of development. How exactly the specificity of epigenetic modifications is accomplished is not completely realised. To exemplify this, DNMTs do not have specificity, and thus, there must be an interplay between chromatin modifiers and cellular components to accomplish the correct recruitment of enzymes involved in epigenetic modification. However, it is clear that the epigenomes of workers vs queen bees are decidedly different and thus are the cause of different physiological and behavioural characteristics. Written by Isobel Cunningham Related articles: An introduction to epigenetics / Famine-induced epigenetic changes Project Gallery

Through AI Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Revolutionising sustainable agriculture 11/07/25, 09:51 Last updated: Published: 27/06/23, 15:34 Through AI Artificial Intelligence (AI) is taking the world by storm. Recent developments now allow scientists to integrate AI into sustainable farming. Through transforming the way we grow crops, manage resources and pests, and most importantly- protect the environment. There are many applications for AI in agriculture. Outlined below are some of the areas in which the incorporation of AI systems improves sustainability: Precision farming Artificial intelligence systems help improve the overall quality and accuracy of harvesting – known as precision farming. Artificial intelligence technology helps detect plant diseases, pests, and malnutrition on farms. AI sensors can detect and target weeds, then decide what herbicide to use in an area. This helps reduce the use of herbicides and lower costs. Many tech companies have developed robots that use computer vision and AI to monitor and precisely spray weeds. These robots can eliminate 80% of the chemicals normally sprayed on crops and reduce herbicide costs by 90%. These intelligent AI sprayers can drastically reduce the amount of chemicals used in the field, improving product quality, and lowering costs. Vertical farming Vertical farming is a technique in which plants are grown vertically by being stacked on top of each other (usually indoors) as opposed to the ‘traditional way’ of growing plants and crops on big strips of land. This approach offers several benefits for sustainable agriculture and waste reduction. The use of AI brings even more significant advancements making vertical farming more sustainable and efficient- Intelligent Climate Control: AI can use algorithms to measure and monitor temperature, humidity, and lighting conditions to optimise climate control in vertical farms. Thus, reducing energy consumption and improving resource efficiency. Creating an enhanced climate-controlled environment also allows for repeatable and programmable crop production. Predictive Plant Modelling: the difference between a profitable year and a failed harvest can just be the specific time the seeds were sowed. By using AI, farmers can use predictive analysis tools to determine the exact date suitable for sowing seeds for maximum yield and reduce waste from overproduction. Automated Nutrient Monitoring: to optimise plant nutrition, AI systems monitor and adjust nutrient levels in hydroponic (plants immersed in nutrient containing water) and aeroponic setups (plants growing outside the soil, with nutrients being provided by spraying the roots). Genetic engineering AI plays a pivotal role in genetic engineering, enhancing the sustainability and precision of crop modification through- Targeted Gene Editing: AI algorithms help in gene editing to produce desirable traits in crops, such as resistance to disease or improved nutritional content. This allows genetic modification without the need to conduct extensive field trials. Thus, saving time and resources. Computational Modelling: by combining AI modelling with gene prediction, farmers will be able to predict which combinations of genes have the potential to increase crop yield. Pest management and disease detection Artificial intelligence solutions such as smart pest detection systems are being used to monitor crops for signs of pests and diseases. These systems detect changes in the environment such as temperature, humidity, and soil nutrients, then alert farmers when something is wrong. This allows farmers to act quickly and effectively, taking preventive measures before pests cause significant damage. Another way to achieve this is by using computer vision and image processing techniques. AI can detect signs of pest infestation, nutrient deficiencies and other issues that can affect yields. This data can help farmers make informed decisions about how to protect their crops. By incorporating AI into these aspects of sustainable agriculture, farmers can achieve high yields, reduce waste and enable more sustainable farming practices, reducing environmental impacts while ensuring efficient food production. Written by Aleksandra Zurowska Related articles: Digital innovation in rural farming / Plant diseases and nanoparticles Project Gallery

Powering life and causing death Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Dual Role of Mitochondria 11/07/25, 09:57 Last updated: Published: 13/05/24, 13:38 Powering life and causing death Mitochondria as mechanisms of apoptosis Mitochondria are famous for being the “powerhouse of cells” and producing ATP for respiration by being the site for the Krebs cycle, the electron transport chain and the location of electron carriers. However, one thing mitochondria are not known for is mediating programmed cell death, or apoptosis. This is a tightly controlled process within a cell to prevent the growth of cancer cells. One way apoptosis occurs is through the mitochondria initiating protein activation in the cytosol (a part of the cytoplasm). Proteins such as cytochrome c activate caspases by binding to them, causing cell death. Caspases are enzymes that degrade cellular components so they can be removed by phagocytes. Mitochondrial apoptosis is also controlled by the B cell lymphoma 2 (BCL-2) family of proteins. They are split into pro-apoptotic and pro-survival proteins, so the correct balance of these two types of BCL-2 proteins is important in cellular life and death. Regulation and initiation of mitochondrial apoptosis Mitochondrial apoptosis can be regulated by the BCL-2 family of proteins. They can be activated due to things such as transcriptional upregulation or post-translational modification. Transcriptional upregulation is when the production of RNA from a gene is increased. Post-translational modification is when chemical groups (such as acetyl groups and methyl groups) are added to proteins after they have been translated from RNA. This can change the structure and interactions of proteins. After one of these processes, BAX and BAK (some examples of pro-apoptotic BCL-2 proteins) are activated. They form pores in the mitochondrial outer membrane in a process called mitochondrial outer membrane permeabilisation (MOMP). This allows pro-apoptotic proteins to be released into the cytosol, leading to apoptosis. Therapeutic uses of mitochondria Dysregulation of mitochondrial apoptosis can lead to many neurological and infectious diseases, such as neurodegenerative diseases and autoimmune disorders, as well as cancer. Therefore, mitochondria can act as important drug targets, providing therapeutic opportunities. Some peptides and proteins are known as mitochondriotoxins or mitocans, and they are able to trigger apoptosis. Their use has been investigated for cancer treatment. One example of a mitochondriotoxin is melittin, the main component in bee venom. This compound works by incorporating into plasma membranes and interfering with the organisation of the bilayer by forming pores, which stops membrane proteins from functioning. Drugs consisting of melittin have been used as treatments for conditions such as rheumatoid arthritis and multiple sclerosis. It has also been investigated as a potential treatment for cancer, and it induced apoptosis in certain types of leukaemia cells. This resulted in the downregulation of BCL-2 proteins, meaning there was decreased expression and activity.The result of the melittin-induced apoptosis is a preclinical finding, and more research is needed for clinical applications. This shows that mechanisms of mitochondrial apoptosis can be harnessed to create novel therapeutics for diseases such as cancer. It is evident that mitochondria are essential for respiration but also involved in apoptosis. Moreover, mitochondria are regulated by the activation of proteins like BCL-2, BAX and BAK. With further research, scientists can develop more targeted and effective drugs to treat various diseases associated with mitochondria. Written by Naoshin Haque Project Gallery